Search Results 151-160 of 35913 for Two-phase

  1. A Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) as Monotherapy or in Combination With Avastin (Bevacizumab) Compared to Sunitinib in Patients With Untreated Advanced Renal Cell Carcinoma [IMmotion150] - Mayo Clinic

    A Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) as Monotherapy or in Combination With Avastin (Bevacizumab) Compared to Sunitinib in Patients ...

  2. A Phase 2 Trial Of ALN-APP In Patients With Cerebral Amyloid Angiopathy - Mayo Clinic

    The study will be conducted over 2 periods: a 24-month double-blind treatment period and an optional 18-month open-label extension (OLE) period. The estimated ...

  3. Cancer Clinical Trials - Mayo Clinic Research

    Patients will be enrolled in two stages: dose escalation stage (Stage ... phase 2 dose (RP2D) to be used in subsequent development of PRT3789. A Study ...

  4. Metastatic Melanoma Clinical Trials - Mayo Clinic Research

    The primary objective of Phase 2 is to determine confirmed objective response rate (ORR) for treatment with first-line CMP-001 in combination with nivolumab ...

  5. Neurology - Clinical trials

    To accomplish this aim CREST-H will add on to the NINDS-sponsored CREST-2 trial (parallel, outcome-blinded Phase ... stage (PAF), and even at a prodromal stage ( ...

  6. A Phase 1B Dose-escalation Study of TRC105 in Combination With Pazopanib in Patients With Advanced Soft Tissue Sarcoma - Mayo Clinic

    The purpose of the phase 2 portion is to estimate the PFS of patients with advanced soft tissue sarcoma by RECIST 1.1. Participation eligibility. Participant ...

  7. Clinical trials - Oncology (Medical)

    This phase III trial studies whether inotuzumab ... The first part of the study includes the first two phases of therapy: Induction and Consolidation.

  8. Treatment of recurrent CDI: Examining the efficacy and safety of standardized live biotherapeutics as microbiota restoration therapies - Mayo Clinic

    CDI typically occurs after a two-step process — antibiotics use that disrupts or creates a gap in the microbiome and exposure to C. difficile spores ...

  9. Phase 3 Study With Dual Release Ciprofloxacin for Inhalation in Non-CF Bronchiectasis - Mayo Clinic

    The DRCFI treatment will influence the time to first pulmonary exacerbation compared to placebo. Participation eligibility. Participant eligibility includes age ...

  10. Neurology - Clinical trials

    The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...